论文信息 - Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt - 字舞流文

Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt

G. Elsisi | A. Noor | D. Almasri | J. Carapinha | Noha Rashad | H. Khaled | A. Foad | Yousery Nada | M. A. Zaidy